News
U.S.-listed shares of Novo Nordisk (NVO) declined 4% in premarket trading Friday on the surprise news that CEO Lars ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback